Search results
Results from the WOW.Com Content Network
Prism adaptation. Prism adaptation is a sensory-motor adaptation that occurs after the visual field has been artificially shifted laterally or vertically. It was first introduced by Hermann von Helmholtz in late 19th-century Germany as supportive evidence for his perceptual learning theory (Helmholtz, 1909/1962). [1]
The prism cover test ( PCT) is an objective measurement and the gold standard in measuring strabismus, i.e. ocular misalignment, or a deviation of the eye. [1] It is used by ophthalmologists and orthoptists in order to measure the vertical and horizontal deviation and includes both manifest and latent components. [1]
Common (1–10% incidence) adverse effects include: Anaemia. Thrombocytopenia. Hyperthyroidism. TSH -increased. Dehydration. High blood potassium. High blood calcium. Ringing in the ears.
A regular prism is a prism with regular bases. Uniform prism. A uniform prism or semiregular prism is a right prism with regular bases and all edges of the same length. Thus all the side faces of a uniform prism are squares. Thus all the faces of a uniform prism are regular polygons. Also, such prisms are isogonal; thus they are uniform polyhedra.
List of side effects of estradiol which may occur as a result of its use or have been associated with estrogen and/or progestogen therapy includes:
Glasses, surgery [3] Frequency. ~2% (children) [3] Strabismus is a vision disorder in which the eyes do not properly align with each other when looking at an object. [2] The eye that is pointed at an object can alternate. [3] The condition may be present occasionally or constantly. [3]
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, but gynecomastia is generally reported to occur in 70 to 80% of patients. In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide monotherapy.
Hydroxychloroquine. Hydroxychloroquine, sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda.